Immunic to Participate in Investor and Scientific Conferences in February
Press Releases
Immunic, Inc.  
February 4, 2025

Immunic to Participate in Investor and Scientific Conferences in February

NEW YORK, Feb. 4, 2025 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases,

avatar profile Olean Times Herald

Olean Times Herald


Local & Social